Cargando…

2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade

Surveillance for emerging human influenza virus clades is important for identifying changes in viral fitness and assessing antigenic similarity to vaccine strains. While fitness and antigenic structure are both important aspects of virus success, they are distinct characteristics and do not always c...

Descripción completa

Detalles Bibliográficos
Autores principales: Swanson, Nicholas J, Marinho, Paula, Dziedzic, Amanda, Jedlicka, Anne, Liu, Hsuan, Fenstermacher, Katherine, Rothman, Richard, Pekosz, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980287/
https://www.ncbi.nlm.nih.gov/pubmed/36865250
http://dx.doi.org/10.1101/2023.02.26.530085
_version_ 1784899883919998976
author Swanson, Nicholas J
Marinho, Paula
Dziedzic, Amanda
Jedlicka, Anne
Liu, Hsuan
Fenstermacher, Katherine
Rothman, Richard
Pekosz, Andrew
author_facet Swanson, Nicholas J
Marinho, Paula
Dziedzic, Amanda
Jedlicka, Anne
Liu, Hsuan
Fenstermacher, Katherine
Rothman, Richard
Pekosz, Andrew
author_sort Swanson, Nicholas J
collection PubMed
description Surveillance for emerging human influenza virus clades is important for identifying changes in viral fitness and assessing antigenic similarity to vaccine strains. While fitness and antigenic structure are both important aspects of virus success, they are distinct characteristics and do not always change in a complementary manner. The 2019–20 Northern Hemisphere influenza season saw the emergence of two H1N1 clades: A5a.1 and A5a.2. While several studies indicated that A5a.2 showed similar or even increased antigenic drift compared with A5a.1, the A5a.1 clade was still the predominant circulating clade that season. Clinical isolates of representative viruses from these clades were collected in Baltimore, Maryland during the 2019–20 season and multiple assays were performed to compare both antigenic drift and viral fitness between clades. Neutralization assays performed on serum from healthcare workers pre- and post-vaccination during the 2019–20 season show a comparable drop in neutralizing titers against both A5a.1 and A5a.2 viruses compared with the vaccine strain, indicating that A5a.1 did not have antigenic advantages over A5a.2 that would explain its predominance in this population. Plaque assays were performed to investigate fitness differences, and the A5a.2 virus produced significantly smaller plaques compared with viruses from A5a.1 or the parental A5a clade. To assess viral replication, low MOI growth curves were performed on both MDCK-SIAT and primary differentiated human nasal epithelial cell cultures. In both cell cultures, A5a.2 yielded significantly reduced viral titers at multiple timepoints post-infection compared with A5a.1 or A5a. Receptor binding was then investigated through glycan array experiments which showed a reduction in receptor binding diversity for A5a.2, with fewer glycans bound and a higher percentage of total binding attributable to the top three highest bound glycans. Together these data indicate that the A5a.2 clade had a reduction in viral fitness, including reductions in receptor binding, that may have contributed to the limited prevalence observed after emergence.
format Online
Article
Text
id pubmed-9980287
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-99802872023-03-03 2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade Swanson, Nicholas J Marinho, Paula Dziedzic, Amanda Jedlicka, Anne Liu, Hsuan Fenstermacher, Katherine Rothman, Richard Pekosz, Andrew bioRxiv Article Surveillance for emerging human influenza virus clades is important for identifying changes in viral fitness and assessing antigenic similarity to vaccine strains. While fitness and antigenic structure are both important aspects of virus success, they are distinct characteristics and do not always change in a complementary manner. The 2019–20 Northern Hemisphere influenza season saw the emergence of two H1N1 clades: A5a.1 and A5a.2. While several studies indicated that A5a.2 showed similar or even increased antigenic drift compared with A5a.1, the A5a.1 clade was still the predominant circulating clade that season. Clinical isolates of representative viruses from these clades were collected in Baltimore, Maryland during the 2019–20 season and multiple assays were performed to compare both antigenic drift and viral fitness between clades. Neutralization assays performed on serum from healthcare workers pre- and post-vaccination during the 2019–20 season show a comparable drop in neutralizing titers against both A5a.1 and A5a.2 viruses compared with the vaccine strain, indicating that A5a.1 did not have antigenic advantages over A5a.2 that would explain its predominance in this population. Plaque assays were performed to investigate fitness differences, and the A5a.2 virus produced significantly smaller plaques compared with viruses from A5a.1 or the parental A5a clade. To assess viral replication, low MOI growth curves were performed on both MDCK-SIAT and primary differentiated human nasal epithelial cell cultures. In both cell cultures, A5a.2 yielded significantly reduced viral titers at multiple timepoints post-infection compared with A5a.1 or A5a. Receptor binding was then investigated through glycan array experiments which showed a reduction in receptor binding diversity for A5a.2, with fewer glycans bound and a higher percentage of total binding attributable to the top three highest bound glycans. Together these data indicate that the A5a.2 clade had a reduction in viral fitness, including reductions in receptor binding, that may have contributed to the limited prevalence observed after emergence. Cold Spring Harbor Laboratory 2023-02-26 /pmc/articles/PMC9980287/ /pubmed/36865250 http://dx.doi.org/10.1101/2023.02.26.530085 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Swanson, Nicholas J
Marinho, Paula
Dziedzic, Amanda
Jedlicka, Anne
Liu, Hsuan
Fenstermacher, Katherine
Rothman, Richard
Pekosz, Andrew
2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade
title 2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade
title_full 2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade
title_fullStr 2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade
title_full_unstemmed 2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade
title_short 2019–20 H1N1 clade A5a.1 viruses have better in vitro replication compared with the co-circulating A5a.2 clade
title_sort 2019–20 h1n1 clade a5a.1 viruses have better in vitro replication compared with the co-circulating a5a.2 clade
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980287/
https://www.ncbi.nlm.nih.gov/pubmed/36865250
http://dx.doi.org/10.1101/2023.02.26.530085
work_keys_str_mv AT swansonnicholasj 201920h1n1cladea5a1viruseshavebetterinvitroreplicationcomparedwiththecocirculatinga5a2clade
AT marinhopaula 201920h1n1cladea5a1viruseshavebetterinvitroreplicationcomparedwiththecocirculatinga5a2clade
AT dziedzicamanda 201920h1n1cladea5a1viruseshavebetterinvitroreplicationcomparedwiththecocirculatinga5a2clade
AT jedlickaanne 201920h1n1cladea5a1viruseshavebetterinvitroreplicationcomparedwiththecocirculatinga5a2clade
AT liuhsuan 201920h1n1cladea5a1viruseshavebetterinvitroreplicationcomparedwiththecocirculatinga5a2clade
AT fenstermacherkatherine 201920h1n1cladea5a1viruseshavebetterinvitroreplicationcomparedwiththecocirculatinga5a2clade
AT rothmanrichard 201920h1n1cladea5a1viruseshavebetterinvitroreplicationcomparedwiththecocirculatinga5a2clade
AT pekoszandrew 201920h1n1cladea5a1viruseshavebetterinvitroreplicationcomparedwiththecocirculatinga5a2clade